# Basil Systems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/basil-systems

- Industry: Software
- Headquarters: Boston, US
- Website: www.basilsystems.com
- Total disclosed funding: $7.5M
- Latest round: Series A (Apr 29, 2025)
- Investors on record: 8

## About

Basil Systems, Inc. delivers advanced AI-enabled data and analytics solutions designed specifically for the life sciences sector, focusing on enhancing decision-making in pharmaceutical and MedTech industries.Basil Systems, Inc. was founded in 2019 and operates out of Boston, US, providing data solutions tailored for the pharmaceutical and MedTech sectors. The company has completed a total of 3 deals, with its most recent funding round occurring on 29 April 2025. Basil Systems raised USD 11.5 mn in a Series A round led by Golden Ventures, with additional participation from Argosy Capital and Hearst Ventures. The company was founded by individuals with a history in the industry, although specific details of their backgrounds are not provided.Basil Systems specializes in advanced AI-enabled data and analytics solutions tailored for the life sciences sector, specifically targeting pharmaceutical and medical technology (MedTech) industries. Their core offerings include the BasilIntel platforms for both Pharma and MedTech, which integrate extensive data sources such as clinical trial, labeling, safety, and adverse event information to facilitate informed decision-making and strategy formulation throughout the product lifecycle. The solutions are designed to drive faster regulatory approvals, optimize market entry, and enhance product innovation while addressing challenges in regulatory compliance and market dynamics. Basil Systems serves a diverse clientele that includes pharmaceutical companies, MedTech firms, clinical research organizations (CROs), and legal entities across various geographical markets, including North America, Europe, and Asia-Pacific.Basil Systems operates primarily on a subscription-based revenue model, providing clients with access to its SaaS platforms, such as BasilIntel and BasilLink. These platforms deliver comprehensive data analytics and insights, enabling organizations to make data-driven decisions efficiently. Revenue is generated through the licensing of these platforms, allowing clients to leverage advanced analytics for their internal and external data needs. Clients typically enter annual subscription agreements, which may include tiered pricing structures based on the scale of data usage and the range of services utilized. The company’s flagship offerings are integral in helping clients navigate the complexities of the life sciences landscape, offering insights that support product lifecycle management and strategic planning.Basil Systems plans to utilize the recent funding of USD 11.5 mn from the Series A round to enhance its data tools, improve integration with customer systems, and expand services related to regulation and safety in the drug and medical device industries. The company is focused on launching new products designed to further streamline analytics capabilities for clients in the life sciences sector. Additionally, Basil Systems aims to expand its footprint into new geographic regions, specifically targeting markets in Europe and Asia-Pacific by the end of 2026.

## Funding rounds

- Series A, Apr 29, 2025, $5M — Hearst Ventures, Golden Ventures, Argosy Healthcare Partners
- Seed, Dec 16, 2021, $2.5M — Hearst Ventures, Golden Ventures, Wild Basin Investments, Alumni Ventures Group, Untapped Capital, Looking Glass Capital, Ensemble VC

## Investors

- Hearst Ventures (https://capitalatlas.ai/funds/hearst-ventures) — Seed, Series A
- Golden Ventures (https://capitalatlas.ai/funds/golden-ventures) — Seed, Series A
- Wild Basin Investments (https://capitalatlas.ai/funds/wild-basin-investments) — Seed
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Seed
- Untapped Capital (https://capitalatlas.ai/funds/untapped-capital) — Seed
- Looking Glass Capital (https://capitalatlas.ai/funds/looking-glass-capital) — Seed
- Ensemble VC (https://capitalatlas.ai/funds/ensemble-vc) — Seed
- Argosy Healthcare Partners (https://capitalatlas.ai/funds/argosy-healthcare-partners) — Series A